Pearson Lab retweeted

UChicago Medicine Comprehensive Cancer Center@UCCancerCenterJun 8
United States
United StatesConnected via United States App StoreAccount-level information, not a live location or per-post device.
Congratulations to #SlideflowLabs, @UChicago spun out cancer pathology AI company on winning Rattan L. Khosa First Place Prize. #SlideflowLabs enables hospitals to run cancer biomarkers in-house with faster turnaround times. @lab_pearson @UChicagoPath
ow.ly/eTYS50Z8NRA
Pearson Lab retweeted
🤖 Join the Artificial Intelligence in Cancer Research Summer School 2025 hosted by @IstTumori- A pioneering event where cutting-edge technology meets life-saving medical innovation. More info ➡️ aicancer2025.org
Pearson Lab retweeted

UChicago Medicine Comprehensive Cancer Center@UCCancerCenter2 Jun 2025
United States
United StatesConnected via United States App StoreAccount-level information, not a live location or per-post device.
At #ASCO25, Frederick Howard, MD, presents a poster showing high efficiency of AI models that accurately predicts treatment outcomes in breast cancer patients, offering a faster, more scalable alternative to traditional genomic testing.
@fredhow @lab_pearson @UChicagoHemOnc
Pearson Lab retweeted

UChicago Medicine Comprehensive Cancer Center@UCCancerCenter31 May 2025
United States
United StatesConnected via United States App StoreAccount-level information, not a live location or per-post device.
From ambient dictation tools to FDA-approved diagnostics, #AI is transforming oncology!
At #ASCO25, Alexander Pearson, MD, PhD presents how AI is reshaping clinical cancer care—from research to bedside. @UChicagoMed @UChicagoHemOnc @lab_pearson
Pearson Lab retweeted
🧐Our DEPEND trial is out! Neoadjuvant nivo/chemo followed by response-stratified CRT in HPV-negative stage IVa/b HNSCC. @UCCancerCenter @UChicagoHemOnc @ajuloorimd @lab_pearson @HNCancerDoc @EIzumchenko @eevokes jamanetwork.com/journals/jam…
Pearson Lab retweeted
The #callforabstracts for our annual AI for Oncology conference in @IstTumori (May 8-9, 2025) is open until Feb 3rd - aiforoncology.it/call-for-ab… We really look forward to your submissions! And the top 3 will have the chance to present in front of a stellar lineup - don't miss it!
Pearson Lab retweeted

Nature Biotechnology@NatureBiotech14 Mar 2024
United States
United StatesConnected via United States Android AppAccount-level information, not a live location or per-post device.
Generative artificial intelligence for drug discovery: how the first AI-discovered and AI-designed drug progressed to phase 2 clinical testing
#behindthepaper communities.springernature.c…
Pearson Lab retweeted
Honored to present our translational research at @TheVFoundation symposium. Thank you for the invtation and your support! @UCCancerCenter @UChicagoMed @UChicagoHemOnc @UofC @UChicagoCCB
It’s personal for our researchers. @AkashPatnaik7 from @UChicagoMed shares how he lost his uncle to prostate cancer and how that gave him the drive to research this type of cancer.
Pearson Lab retweeted
Incredibly excited to share our open-source Common Longitudinal ICU data Format (CLIF)! We hope CLIF will substantially improve the efficiency of critical illness research and evaluation of important ICU quality measures
Appreciate any and all feedback!
🚨 Just released! 🚨 Excited to share our new preprint on the Common Longitudinal ICU Data Format (CLIF)! This open-source format standardizes ICU data for federated research, advancing AI and critical care research. Check it out: (medrxiv.org/content/10.1101/…) #ICU #DataScience #AI
Pearson Lab retweeted
🚀 Big news! Slideflow 3.0 is here! 🎉 We've revamped our licensing (now Apache-2.0) to make Slideflow more open & accessible. We've added 3 foundation models (Virchow, UNI, GigaPath), upgraded MIL, & much more. Check it out: github.com/slideflow/slidefl… #AI #Pathology #OpenSource
Pearson Lab retweeted
Check out our multi-center phase 2 IIT currently accruing for upfront SBRT added to Durvalumab-based chemoimmunotherapy for the first line treatment of extensive stage SCLC - the DARES trial. @ChristineBestv1 @Docace911
clinical-lung-cancer.com/art…
Pearson Lab retweeted
U.S. News & World Report's Best Hospitals list ranked University of Chicago Medical Center's Cancer and ENT programs highest in Illinois. Additionally, UCMC is one of only 25 hospitals nationwide to have at least 10 ranked specialties. uchicagomedicine.org/forefro…
Pearson Lab retweeted
Priviliged to have spent 4 days with friends and colleagues from all over the 🌎in the beautiful historic setting of AKSS Spetses for the first “Workshop on AI in Oncology: applications & challenges”.
We interacted and learned from AI experts, delved into the exciting new world of AI possibilities and dynamic potentials in oncology, laughed and shared amazing moments in Spetses, the island of unique energy, cherished and celebrated old friendships and fostered new ones, enjoyed a few unforgettable days of togetherness.
And also organised and followed our @I3Lung annual meeting, celebrating 2 years of working together!
thank you all for coming, each one has and is making an incredible difference and together we rock!
Safe travels back home to everyone and see you all next year! ❤️
Pearson Lab retweeted

UChicago Medicine Comprehensive Cancer Center@UCCancerCenter13 Jun 2024
United States
United StatesConnected via United States App StoreAccount-level information, not a live location or per-post device.
Replying to @fredhow
@fredhow and colleagues published a great study in @JCOCCI_ASCO during #ASCO24 reporting increased use of AI tools in scientific writing, warning authors to be responsible for accurate representation of content.
@lab_pearson @UChicagoHemOnc @UCCancerCenter
ow.ly/hUTB50Sim17
Pearson Lab retweeted

UChicago Medicine Comprehensive Cancer Center@UCCancerCenter10 Jun 2024
United States
United StatesConnected via United States App StoreAccount-level information, not a live location or per-post device.
OPTIMA II trial results published in @JAMAOnc demonstrating beneficial outcomes with neoadjuvant immunotherapy & chemotherapy in high risk HPV+ #OPC pts. @eevokes @AriRosenbergMD @lab_pearson @ajuloorimd @HNCancerDoc @UCCancerCenter @UChicagoHemOnc
ow.ly/1KXw50Sc2A1
Pearson Lab retweeted

UChicago Medicine Comprehensive Cancer Center@UCCancerCenter7 Jun 2024
United States
United StatesConnected via United States App StoreAccount-level information, not a live location or per-post device.
Huge congratulations to our rising stars, Fred Howard, MD (@fredhow) and Anand Patel, MD (@Anand_88_Patel) on receiving #40Under40 in Cancer award.🎉🎉🎉
@UCCancerCenter @UChicagoHemOnc
ow.ly/a42250SbUxO
Pearson Lab retweeted
Excellent presentation by @lab_pearson of pathway study #ASCO24 demonstrating improved PFS with pembrolizumab vs placebo in high risk #headandneckcancer particularly among salvage surgery and multiply recurrent subsets @UCCancerCenter
Pearson Lab retweeted

UChicago Medicine Comprehensive Cancer Center@UCCancerCenter1 Jun 2024
United States
United StatesConnected via United States App StoreAccount-level information, not a live location or per-post device.
Replying to @fredhow
@fredhow presents an excellent poster at #ASCO24 showing increased use of ChatGPT in generating scientific abstracts directed towards need to bring new policies.
@Lab_Pearson @UCCancerCenter @UChicagoHemOnc
Pearson Lab retweeted

UChicago Medicine Comprehensive Cancer Center@UCCancerCenter1 Jun 2024
United States
United StatesConnected via United States App StoreAccount-level information, not a live location or per-post device.
Replying to @lab_pearson
@lab_pearson chairs an AI session at #ASCO24 and discusses two excellent abstracts that used prognostic and predictive multi-modal models in breast cancer and non-small cell lung cancer.
@UCCancerCenter @UChicagoHemOnc
Pearson Lab retweeted
Congratulations to @fredhow @lab_pearson Dezheng Huo MD/PhD @RitaNandaMD Charles Perou PhD @UNC_Lineberger & Galina Khramtsova MD/PhD for receiving the @ALLIANCE_org Foundation Special Projects Allocation Award. #AllianceSpring24 #NCI #NCTN #NCORP #CancerResearch @UCCancerCenter






































